Novavax vaccine, “current adherence to this vaccine appears to be limitedbecause of perception that the pandemic is fading“. Marco Cavaleri, head of Vaccines and Covid-19 Therapeutic Products of the European Medicines Agency Ema, expressed this fear today during the periodic briefing with the press.
“And instead – objected the expert – it is of the utmost importance that anyone who has not yet taken any dose takes the opportunity to get vaccinated as soon as possible, taking into account the broadest portfolio of options that is now available”.
“The Covid vaccine from Novavax Nuvaxovid and beyond has been launched in Europe in recent weeks 3.7 million doses have been distributed to date according to the ECDC“, European Center for Disease Prevention and Control.
